Pubblicazioni

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events

2018 - ANNALS OF HEMATOLOGY

Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; FoÃ , Robin; Breccia, Massimo

Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

2017 - HEALTH AND QUALITY OF LIFE OUTCOMES

Breccia, Massimo; Baccarani, Michele; Rosti, Gianantonio; Cottone, Francesco; Cannella, Laura; Guilhot, FranÃ§ois; Vignetti, Marco; Efficace, Fabio